Diagnosing nociplastic pain in cancer survivors: a major step forward.

Br J Anaesth

CETD, Ambroise Pare Hospital, APHP, Boulogne-Billancourt, France; Inserm U987, UVSQ-Paris-Saclay University, Ambroise Pare Hospital, APHP, Boulogne-Billancourt, France. Electronic address:

Published: May 2023

Nociplastic pain syndromes include particular fibromyalgia, irritable bowel syndrome, headache, complex regional pain syndrome, and idiopathic orofacial pain. Several mechanisms have been proposed to account for nociplastic pain including central sensitisation, alterations of pain modulatory controls, epigenetic changes, and peripheral mechanisms. Importantly, nociplastic pain might also be present in patients with cancer pain, particularly those with pain related to complications of cancer treatment. Increased awareness of nociplastic pain associated with cancer should have important implications for monitoring and managing such patients.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bja.2023.02.006DOI Listing

Publication Analysis

Top Keywords

nociplastic pain
20
pain
10
diagnosing nociplastic
4
cancer
4
pain cancer
4
cancer survivors
4
survivors major
4
major step
4
step forward
4
nociplastic
4

Similar Publications

The number of central nervous system-driven symptoms predicts subsequent chronic primary pain: evidence from UK Biobank.

Br J Anaesth

January 2025

Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK; Department of Rheumatology, Mayo Clinic, Jacksonville, FL, USA.

Background: Chronic primary pain describes conditions where pain is the principal problem rather than a consequence of another disease. Primary pain is thought to be primarily owing to nociplastic pain (i.e.

View Article and Find Full Text PDF

Sex-Specific Sensory Profiles Discriminate Between Sensitization at Twelve Weeks in Patients with Acute Low Back Pain: A Retrospective Study.

J Clin Med

January 2025

Experimental Anatomy Research Group, Department of Physiotherapy, Human Physiology and Anatomy, Faculty of Physical Education and Physiotherapy, Vrije Universiteit Brussel, Laarbeeklaan 103, 1090 Brussels, Belgium.

Low back pain (LBP) is the leading cause of disability worldwide, resulting in enormous socio-economic and personal consequences. Sensory profiles during the acute back pain stage will predict central sensitization symptoms in the chronic pain stage, as central sensitization is the main mechanism behind nociplastic pain and pain chronicity. Therefore, our objective was to establish overall and sex-specific sensory profile cut-off points that distinguish symptoms of central sensitization at 12 weeks, using a retrospective prognostic cohort study design.

View Article and Find Full Text PDF

Fibromyalgia (FM) is a complex and multifaceted condition characterized by a range of clinical symptoms, including widespread pain and a strong association with migraine headaches. Recent findings have underscored the role of oxidative stress and transient receptor potential ankyrin 1 (TRPA1) channel in migraine and FM. However, the precise mechanisms underlying the comorbidity between migraine and FM are unclear.

View Article and Find Full Text PDF

Nociplastic pain among individuals with chronic ocular surface pain: One cause for "pain without stain"?

Surv Ophthalmol

January 2025

Michigan Medicine, Department of Ophthalmology and Visual Sciences, Ann Arbor, MI, USA.

Chronic ocular surface pain (COSP) refers to interrelated symptoms such as burning, aching, and irritation and can occur as an isolated condition or comorbid with numerous ocular disorders, including dry eye syndrome Treatments for COSP are largely aimed at the ocular surface and modulating pain arising from damaged corneal nerves; however, the average impact of these treatments on COSP are low to absent. A potential explanation for this is that, in a subset of patients with COSP, individuals have amplified and/or dysregulated neural signaling and sensory processing within the central nervous system (CNS). As in other chronic pain conditions, this might be the pathogenic mechanism primarily responsible for maintaining pain - a phenomenon now referred to as nociplastic pain.

View Article and Find Full Text PDF

Meta-Analysis of Palmitoylethanolamide in Pain Management: Addressing Literature Gaps and Enhancing Understanding.

Nutr Rev

January 2025

Diet, Planetary Health and Performance, Faculty of Health Sciences, Universidad Francisco de Vitoria, Pozuelo, Spain.

Article Synopsis
  • Chronic pain affects many people, and Palmitoylethanolamide (PEA) is highlighted as a natural and safe pain management alternative that works through the endocannabinoid system, inflammation modulation, and immune regulation.
  • A meta-analysis of 18 randomized clinical trials with 1,196 patients was conducted to assess the effectiveness of PEA in reducing various types of pain, showing significant pain reduction at multiple time points (6, 8, and 24-26 weeks).
  • The analysis confirmed that PEA not only alleviates pain for nociceptive, neuropathic, and nociplastic types but also improves overall quality of life, with benefits noticeable within the
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!